top of page

A Review of OSA Treatment Outcomes

airway-improvement-surgery

Airway Improvement Surgery (AIS) for OSA Works – it always has & it is even
better today:

Vanderveken and Gagnadoux. Sleep. 2023 Oct 11;46(10).

Key finding: Mean disease alleviation (MDA) is the principle of integrating efficacy and adherence when reporting the true therapeutic effect.  It is given by the product of the efficacy and the adherence for to a treatment. With 100% adherence, sleep surgery has no discrepancy between effectiveness and efficacy in outcomes.

Every et al. SLEEP, 2023, 46, 1-13.

Key finding: In matched patients Multilevel Surgery had a higher level of Mean Disease Alleviation (64%) vs CPAP (57%)

Martin et al. Annals of Otology, Rhinology & Laryngology 2024, Vol. 133(12) 1019–1028.

Key finding: In matched patients at 5, 8 & 20 years, airway improvement sleep surgery had a cardiovascular mortality risk at least 49% lower than that for CPAP

Ebrahim et al. European Archives of Oto-Rhino-Laryngology (2025) 282:2641–2648.

Key finding: Patients grouped by BMI: Normal (N=13), Overweight (N=31), Obese (N=43), and Morbidly Obese (N=22).  Surgical success rates were not affected by obesity, ranging from 72.1% to 84.6%. There was no difference between the groups regarding the reduction of AHI, ESS, SPO2, mean O2 saturation, minimum O2 saturation, apnea index, hypopnea index, VAS, RERA, and the number of minutes of oxygen saturation below 90%.

ais-palate

AIS for the palate - the latest palate modification techniques are very effective:

Kadrie et al. Am J Otolaryngol. 2026 Jan-Feb;47(1):104776.

Key finding: In matched patients, those treated with UPPP have lower rates of acute respiratory failure, pulmonary hypertension, and new-onset atrial fibrillation/flutter than CPAP patients.

Kaffenberger et al. Laryngoscope. 2026 Jun 29.

Key finding: Modern UPPP techniques provide better results than the old traditional techniques, with Sher surgical success rates around 80%.

multi-level-ais

Multi-level AIS: Hyomandibular Suspension with a palate modification achieve
strong outcomes across a broad patient range

Baker et al. Current Otorhinolaryngology Reports. Volume 13, article number 13 (2025).

Key finding: Hyomandibular Suspension with UPPP Surgical Success averages 72.2% with an average AHI reduction of 62.1%.  Hyothyroid techniques had 24% lower results.  The overall AHI reduction for hyoid suspension as a standalone intervention was 51%.

Van Tassel et al.  Ear Nose Throat J. 2023 May;102(5):NP212-NP219.

Key finding: AIRLIFT Hyomandibular Suspension with UPPP had Surgical Success of 77% with an AHI reduction of 69%.

Gibbs et al. Otolaryngol Head Neck Surg, Sleep Medicine Poster Presentations 2022. https://doi.org/10.1177/01945998221107673k

Key finding: Morbidly Obese Patients with a mean BMI of 44.6, achieved a 53% AHI reduction from 54 down to 25.6 (53%) and normalization of ESS from 11.3 down to 7. N = 29.

hypoglossal-nerve-stimulation-data

Hypoglossal Nerve Stimulation Data – how you evaluate outcomes matters
significantly for correct assessment of the Mean Disease Alleviation attained for your patients

Strollo et al. N Engl J Med. 2014 Jan 9;370(2):139-49.

Key finding: Average AHI reduction of 52%.  34% non-responders.  On average, non-responders saw zero AHI reduction.

Dedhia RC, Woodson BT. J Clin Sleep Med. 2018;14(11):1835–1836.

Key finding: Most HGNS publications use treatment AHI.  Treatment AHI is fraught with issues.  Emory HGNS cohort (n = 43) showed:  Mean treatment AHI was 7.7 compared to 19.2 from full-night efficacy.  Sher success was 91% using treatment AHI while 52% using full-night efficacy.

Kaffenberger et al. J Clin Sleep Med. 2025 Jan 1;21(1):47–53.

Key finding: Mean tPSG AHI reduction was 74%  compared to 47% from full-night efficacy.  Sher15 success was 80.3% using treatment AHI while 45.9% using full-night efficacy.

hns-patient-considerations

Hypoglossal Nerve Stimulation – Patient Considerations to Optimize Your Success

Kaki et al. JAMA Otolaryngol Head Neck Surg. 2026 Sep 24:e262816. doi: 10.1001/jamaoto.2026.2816.

Key finding: Low arousal threshold had a lower treatment effect and lower therapy adherence, leading to an effective AHI reduction of only 20.3% in those patients at 6 months.

Patel et al. JAMA Otolaryngol Head Neck Surg. 2024 May 1;150(5):421-428.

Key finding: Higher BMI and supine sleeping position may decrease therapeutic response to HGNS. Patients with BMI of 32 to 35 had 75% lower odds of responding to HGNS compared with those with a BMI of 32 or less. Only 39% of patients who slept in a supine position achieved a treatment response.

Shindhelm et al. Sleep Medicine 146 (2026) 109092.

Key finding: HGNS success by Sher criteria and AHI normalization were 77.0% and 54.1%, respectively, in lateral sleep compared to 52.9% and 23.5% in supine sleep.

Key finding: Increasing BMI was associated lower HGNS efficacy. Among patients with laterally directed collapse, each 5 kg/m2 increase in BMI was associated with a −19.7% reduction in efficacy.  With AP collapse each 5 kg/m2 increase in BMI was associated with a −3.8% reduction. Higher BMI with lateral collapse also reduced odds of treatment success (odds ratio 4.4 per 5 kg/m2).

hns-long-term-care

Hypoglossal Nerve Stimulation – Long-term, Ongoing Burden of Care Considerations

Lenze et al. Sleep Breath. 2025 Jul 18;29(4):249.

Key finding: University of Michigan. Adherence rate was 52.5% @ 9 months. Average AHI reduction was 35.1%.

Linguiti et al. AAO-HNSF Poster 2026.

Key finding: Nearly 50% of patients lost to follow up (LTFU Definition: ≥548 days (1.5 yr)).  Out of 608 implants, 288 were considered LTFU.   For patients LTFU, 39.5% had discontinued HGNS use and 76.5% of these received no alternative OSA therapy.

Mirza et al. ISSS ePoster 2026.

Key finding: 90 patients completed long-term follow up survey.  56.7% of patients were either non-adherent or intermittent users (38 patients non-adherent, 13 intermittent users).  55.6% of patients reported no follow-up in >1 year.

Linguiti et al. AAO-HNSF Poster 2026.

Key finding: Each HGNS procedure generates nearly 7 postoperative visits, a sustained longitudinal care burden that grows as HGNS adoption expands.  This cumulative burden will continue to increase over time, given the need for at least annual long-term follow-up.

Joo et al. Life 2025, 15, 861.

Key finding: Age related cognitive decline, pre-existing cognitive impairments, and sensory deficits such as impaired vision and hearing can complicate the operation and maintenance of such devices, requiring users to follow up more frequently in the clinic for re-education and reassessment of subjective benefits. Intensive involvement of a patient’s care partners as well as comprehensive support and education tailored to these populations are crucial for the effective utilization of the Inspire system.

call: +1 408.320.9424

fax:  +1 408.399.7600 

​

Learn More: 

info@siestamedical.com

Mailing Address:

Siesta Medical, Inc.

101 Church Street, Suite 3

Los Gatos, CA 95030

 

To Order:

sales@siestamedical.com​

©2016-2026 Siesta Medical, Inc.  AIRLIFT, Encore System, and Revolution are trademarks of Siesta Medical, Inc.

  • Facebook - White Circle
  • YouTube - White Circle
  • LinkedIn - White Circle
bottom of page